Clinical Trial Update: A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV [Phase 1]

View source ↗

Summary

This update outlines a Phase 1 study to evaluate tolerability and acceptability of long-acting cabotegravir and lenacapavir injections in healthy adults without…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Apretude (cabotegravir) (cabotegravir)
• Lenacapavir (lenacapavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: ACTIVE_NOT_RECRUITING